In non-small cell lung cancer (NSCLC) and CRC, increased IL-25 expression correlates with worse patient survival and increased intra-tumoral ILC2 and MDSC frequencies (177, 179, 180). The gene discussed is IL25; the disease is non-small cell lung carcinoma.